.Avidity Biosciences amazed investors with phase 1/2 information in Duchenne muscular dystrophy (DMD...
.Actinogen Medical's cortisol blocker has missed the primary endpoint of a phase 2 research in depre...
.Antibody-drug conjugates (ADCs) have gone to the facility of several a billion-dollar biobuck licen...
.Asset supervisor TPG, which has actually sustained biotechs including Sionna Therapeutics as well a...
.Merck & Co.'s TIGIT plan has actually experienced an additional misfortune. Months after shutter...
.After a year determined through pipe cuts, the departure of its own chief executive officer and cut...
.Cullinan Therapeutics was actually made an impression on good enough with Harbour BioMed's bispecif...
.In this week's incident of "The Best Pipe," we're diving into Strong Biotech's yearly Strong 15 uni...
.The confetti is still soaring from Eli Lilly's gathering commemorating the approval of Alzheimer's ...
.Invite to this week's Chutes & Ladders, our summary of significant leadership hirings, firings a...